medical device investing Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017
pharmaceutical investing Final Patient Completes Treatment in First Leg of OncBioMune's Clinical Trial
3d printing investing Organovo Receives Strong Customer Response for ExVive Human Kidney Tissue Launch
3d printing investing Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development
Scripps Research Institute Spin-off iGenomX Launches with Transformational New Library Construction Technology for DNA Sequencing
OncBioMune Enters Joint Venture, Preparation for Phase 2 Trial of Novel Cancer Vaccine for Prostate Cancer Underway
